Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pliant Therapeutics (PLRX) Other Non-Current Liabilities (2019 - 2021)

Pliant Therapeutics (PLRX) has disclosed Other Non-Current Liabilities for 3 consecutive years, with $756000.0 as the latest value for Q3 2021.

  • Quarterly Other Non-Current Liabilities rose 96.88% to $756000.0 in Q3 2021 from the year-ago period, while the trailing twelve-month figure was $756000.0 through Sep 2021, up 96.88% year-over-year, with the annual reading at $866000.0 for FY2020, 5.04% down from the prior year.
  • Other Non-Current Liabilities for Q3 2021 was $756000.0 at Pliant Therapeutics, down from $804000.0 in the prior quarter.
  • The five-year high for Other Non-Current Liabilities was $912000.0 in Q4 2019, with the low at $7000.0 in Q2 2020.
  • Average Other Non-Current Liabilities over 3 years is $652000.0, with a median of $804000.0 recorded in 2021.
  • The sharpest move saw Other Non-Current Liabilities decreased 5.04% in 2020, then soared 11385.71% in 2021.
  • Over 3 years, Other Non-Current Liabilities stood at $912000.0 in 2019, then fell by 5.04% to $866000.0 in 2020, then decreased by 12.7% to $756000.0 in 2021.
  • According to Business Quant data, Other Non-Current Liabilities over the past three periods came in at $756000.0, $804000.0, and $835000.0 for Q3 2021, Q2 2021, and Q1 2021 respectively.